肠易激综合征(IBS)

肠易激综合征(IBS)的相关文献在1995年到2022年内共计96篇,主要集中在内科学、中国医学、药学 等领域,其中期刊论文90篇、专利文献99044篇;相关期刊65种,包括内蒙古中医药、实用中医药杂志、中药药理与临床等; 肠易激综合征(IBS)的相关文献由252位作者贡献,包括M.、E.博尔泰、A.等。

肠易激综合征(IBS)—发文量

期刊论文>

论文:90 占比:0.09%

专利文献>

论文:99044 占比:99.91%

总计:99134篇

肠易激综合征(IBS)—发文趋势图

肠易激综合征(IBS)

-研究学者

  • M.
  • E.博尔泰
  • A.
  • C.帕特森
  • H.
  • J.
  • Liang LIU
  • P.戈登
  • S.
  • Shu-kun YAO
  • 期刊论文
  • 专利文献

搜索

排序:

年份

    • 杨紫玉; 巩仔鹏; 王娅杰; 董宇; 董李晋川; 陈颖; 杨庆; 蔡维艳; 李琦; 翁小刚; 郭雨轩; 朱晓新
    • 摘要: 目的测定戊己丸中10个活性成分单次给药和多次口服给药后不同时间点的血药浓度,比较其在正常大鼠和慢性内脏高敏感肠易激综合征(CVH-IBS)大鼠体内药代动力学特征的差异。方法采用乳鼠结肠球囊刺激法制备CVH-IBS大鼠模型,并对其进行内脏敏感性评价。单次或多次灌胃给予戊己丸提取物后于不同时间点从颈静脉采血,采用超高效液相色谱-串联质谱(UPLC-MS/MS)同时检测血浆中10个戊己丸活性成分的血药浓度,比较其药代动力学参数的差异。结果CVH-IBS大鼠内脏敏感性增强。与单次给药相比,多次给药正常与模型大鼠达峰时间(t_(max))均提前。单次给药后模型与正常大鼠的差异可正向验证前期实验结果。多次给药后与正常大鼠相比,模型大鼠体内戊己丸活性成分血药浓度峰值(C_(max))、曲线下面积(AUC_(0-t))、总清除率(Cl)发生显著改变。盐酸小檗碱、盐酸黄连碱、表小檗碱C_(max)显著升高,盐酸巴马汀、盐酸药根碱、二氢小檗碱、吴茱萸碱、吴茱萸内酯C_(max)显著下降;盐酸黄连碱、表小檗碱AUC_(0-t)显著升高,盐酸巴马汀、二氢小檗碱、盐酸药根碱、吴茱萸碱、吴茱萸内酯AUC_(0-t)显著下降;盐酸黄连碱、吴茱萸内酯Cl明显升高,表小檗碱Cl显著降低。盐酸巴马汀、芍药内酯苷t_(1/2)明显降低;盐酸药根碱V_(d)显著升高。模型大鼠多次给药和单次给药相比较,黄连活性成分盐酸小檗碱、盐酸药根碱、表小檗碱、二氢小檗碱C_(max)明显降低;盐酸药根碱Cl明显降低。白芍活性成分芍药苷t_(1/2)明显下降,Cl明显上升。结论戊己丸中活性成分在正常大鼠、CVH-IBS大鼠、戊己丸治疗后期的CVH-IBS大鼠体内的药代动力学行为存在明显差异,这可能与IBS治疗早期肠道屏障被破坏和治疗后期肠道屏障修复、药物肝肠循环蓄积作用以及肝酶的活性等代谢功能改变相关。
    • 石虹
    • 摘要: 肠易激综合征(irritable bowel syndrome,IBS)是临床常见的一组以腹痛、腹胀、腹部不适伴排便习惯改变为主要症状的临床综合征.近年来,对IBS的认识已从严格意义的胃肠道疾病(生物医学模式)转变为更复杂的多症状的脑-肠轴紊乱(生物-心理-社会模式).本文对生物-心理-社会医学模式在IBS诊断和治疗中的应用进展进行综述.
    • 朱时钰; 杨红卫; 陈俊; 李钊; 陆永利
    • 摘要: 内源性大麻素系统(endocannabinoid system,ECS)由大麻素受体、内源性大麻素以及涉及内源性大麻素合成、运输和降解的酶所构成,广泛参与胃肠道的各种生理和病理生理过程,并且通过大麻素基本调节作用来维持体内肠道的平衡.本文综述了近几年关于内源性大麻素系统在正常胃肠功能与肠易激综合征、炎症性肠病和结肠癌等疾病中作用的主要研究进展,可为临床治疗胃肠道疾病提供有效的理论指导.
    • 邓帅
    • 摘要: 目的 探究心理干预对IBS患者情绪状况及生活质量的影响效果.方法 随机选取我院收治60例IBS患者,将其分为对照组、观察组2组,分别给予常规护理、心理干预措施进行护理,对比分析两组护理效果情况.结果 观察组护理后患者的焦虑、抑郁评分(38.69±1.79)分、(35.44±1.88)分,与对照组患者的(46.64±2.45)分、(47.51±2.60)分相比明显较低,差异有统计学意义(P<0.05).观察组护理后患者的情感得分、健康指数、生活满意度及感情指数与对照组患者的相比明显较高(P<0.05).结论 心理干预对IBS患者情绪状况及生活质量的影响效果显著,改善患者焦虑、抑郁情绪,临床意义重大.
    • 吴铭; 黄柳燕; 陈聪; 雷清云; 李定宏; 张国栋
    • 摘要: 益生菌是一类可对机体产生有益作用的微生物,可通过改善宿主胃肠道微生物平衡从而对机体产生有利影响.近年来,研究发现人为植入益生菌竞争拮抗胃肠道致病菌的作用已经越来越受到国内外学者的重视.胃肠道益生菌已经被证实能够通过抑制胃肠道致病菌防治慢性胃炎、胃溃疡、腹泻、肠易激综合征、新生儿坏死性小肠结肠炎等胃肠道疾病.本文综述了益生菌对胃肠道相关疾病的影响及发挥作用的机制,为进一步应用益生菌提高胃肠道疾病临床治疗效果等提供理论基础,并胃肠道疾病提供新的治疗方法和思路.
    • 陈焕钊; 陈锦辉
    • 摘要: 目的:观察中药痛泻参苓白术汤(自拟方)加西药双歧三联活菌胶囊(培菲康)等治疗腹泻型肠易激综合征的临床疗效.方法:将100例腹泻型肠易激综合征患者随机分为两组,治疗组50例,给予中药痛泻参苓白术汤(自拟方),配合西药双歧三联活菌胶囊(培菲康)等进行治疗;对照组50例,单独给予中药痛泻参苓白术汤(自拟方),与治疗组中药同样,每天1剂,水煎服,两组均以4周为1个疗程.疗程结束后比较临床疗效.结果:治疗组显效35例(70%);有效15例(30%);总有效率100%.对照组显效30例(60%);有效16例(32%);无效4例(8%);总有效率92%.两组差异有统计学意义(P<0.05).结论:痛泻参苓白术汤(自拟方)联合西药双歧三联活菌胶囊(培菲康)等治疗腹泻型肠易激综合征效果显著,可供临床推广.
    • 张婷; 陈玉林
    • 摘要: 目的 探讨肠易激综合征(IBS)患者采取马来酸曲美布汀联合黛力新治疗对血清IL-6的影响.方法 将2016年3月至2017年3月我院86例的IBS患者随机分为观察组(n=43,采取马来酸曲美布汀联合黛力新治疗)与对照组(n=43,单独给予马来酸曲美布汀治疗),对两组患者临床疗效、焦虑、抑郁评分、IL-6水平及安全性进行观察.结果 相较于对照组,观察组患者的治疗总有效率显著较高(P0.05).结论 IBS患者采取黛力联合马来酸曲美布汀治疗的临床效果显著,能够显著缓解患者机体内的炎症反应及不良情绪,安全性良好,具有推广价值.
    • 章海凤; 谢芳深; 龚红斌; 黄辉; 陈树涛; 康明非; 付勇
    • 摘要: 目的:观察热敏灸对肠易激综合征(IBS)大鼠促肾上腺皮质激素释放激素(CRH)、促肾上腺皮质激素(ACTH)、皮质酮(CORT)的影响,探讨热敏灸治疗IBS的可能作用机制.方法:56只SD雄性大鼠按随机数字表随机分为空白组(8只)、模型组(8只)、艾灸组(32只)和米非司酮组(RU-486组,8只).空白组正常饲养,模型组、RU-486组与艾灸组采用慢性不可预见性刺激法建立IBS模型,造模21 d.造模结束后,艾灸组灸"命门"穴,每日1次,每次40 min,共14 d,每隔5 min检测大鼠尾温并记录,根据大鼠尾温变化分热敏灸组和非热敏灸组,两组各随机抽取8只;RU-486组予RU-486灌胃处理,空白组、模型组与艾灸组灌服同等换算体积0.9%NaCl溶液14 d.观察各组大鼠一般状况、体质量、行为学、小肠推进率、内脏敏感性变化,ELISA法检测大鼠血清CRH、ACTH、CORT含量,光学显微镜观察结肠形态学变化.结果:①造模后,大鼠表现为静卧少动、神态怠倦、毛发枯槁、耳郭色泽变暗淡、粪便时干时稀等;体质量增长缓慢;大鼠穿格数、站立数明显减少;内脏敏感性增高、小肠推进率下降;结肠组织显微镜下未见明显炎性细胞浸润.②干预后,与空白组相比,RU-486组体质量、内脏敏感性差异无统计学意义(均P>0.05),但小肠推进率明显下降(P0.05).与模型组相比,RU-486组干预后体质量升高、内脏敏感性改善(P0.05);热敏灸组与非热敏灸组干预后体质量、内脏敏感性、小肠推动率均明显优于模型组(P0.05).结论:热敏灸可能通过调节下丘脑-垂体-肾上腺轴(HPA轴),降低血清CRH、ACTH、CORT含量,改善胃肠运动功能,从而达到治疗IBS的目的.%Objective To observe the effects of heat-sensitive moxibustion on corticotropin releasing hormone (CRH), adrenocorticotrophic hormone (ACTH) and corticosterone (CORT) in rats with irritable bowel syndrome (IBS), and to explore the possible mechanism of heat-sensitive moxibustion on IBS.MethodsAccording to random number table, 56 SD male rats were randomly divided into a blank group (n=8), a model group (n=8), a moxibustion group (n=32), and a mifepristone group (RU-486 group,n=8). The rats in the blank group were treated with normal feeding; the rats in the model group, RU-486 group and moxibustion group were treated with chronic non-predictable stimulation for 21 days to establish IBS model. After model establishment, the rats in the moxibustion group were treated with moxibustion at"Mingmen" (GV 4) for 40 min, once a day for 14 days; the tail temperature was recorded every 5 min; according to the change of tail temperature, the rats were divided into a heat-sensitive moxibustion group and a non-heat-sensitive moxibustion group, and 8 rats were randomly selected in the two groups. The rats in the RU-486 group were treated with gastric administration of RU-486 for 14 days, while the rats in the blank group, model group and moxibustion groups were treated with identical volume of 0.9% NaCl. The rat general condition,body mass,behavioristics, intestinal propulsive rate and visceral sensitivity were observed in each group; ELISA method was used to detect serum CRH,ACTH and CORT; optical microscope was applied to observe the morphological changes of colon.Results(1) After model establishment, rats were in rest state, fatigued, with withered hair and dim ear; the stool was dry or watery; the body mass were slowly increased; the number of crossed grid and standing frequency were significantly reduced; visceral sensitivity was increased and intestinal propulsion rate was decreased; no obvious inflammatory cell infiltration was observed under microscope. (2) After intervention, compared with the blank group, the body mass and visceral sensitivity in the RU-486 group were not significantly different (bothP>0.05), but the intestinal propulsion rate was decreased significantly (P0.05). Compared with the model group, the body mass and visceral sensitivity were improved in the RU-486 group (P0.05). The body mass, visceral sensitivity and intestinal propulsion rate of the heat-sensitive moxibustion group and the non-heat-sensitive moxibustion group were superior to those of the model group (P0.05).Conclusion Heat-sensitive moxibustion could reduce the contents of CRH, ACTH and CORT through the HPA axis, and improve the function of gastrointestinal motility to treat IBS.
    • 尹清珂
    • 摘要: 目的评价双歧三联活菌联合马来酸曲美布汀治疗肠易激综合征的疗效。方法以罗马Ⅲ肠易激综合征诊断标准选取肠易激综合征(IBS)患者30例,随机分成两组:对照组15例,给予马来酸曲美布汀,200mg/次,3次/天;观察组15例,在对照组的基础上加用双歧杆菌三联活菌胶囊,每次2-4粒,2次/天。两组患者的疗程均为4周,记录治疗前后症状并进行疗效评价。结果治疗组的总有效率为93.33%,对照组的总有效率为53.33%,两组间存在显著性差异(P〈0.05)。结论双歧三联活菌片联合马来酸曲美布汀治疗肠易激综合征(IBS)疗效良好,值得临床推广应用。
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号